David L. Lacey insider trades

Open-market stock purchases and sales by David L. Lacey, Director at Arcus Biosciences, Inc, from SEC Form 4 filings since Jun 20, 2019.

Recent trades

DateStockTradeValue
Jun 11, 2026RCUS Arcus Biosciences, IncBought (not open market)—
Jun 11, 2026RCUS Arcus Biosciences, IncBought (not open market)—
May 15, 2026NRIX Nurix Therapeutics, IncBought (not open market)—

Companies traded

  • RCUS Arcus Biosciences, Inc: other filings, last Jun 11, 2026
  • NRIX Nurix Therapeutics, Inc: other filings, last May 15, 2026
  • BCEL Atreca, Inc: other filings, last Jun 13, 2023
  • UBX Unity Biotechnology, Inc: other filings, last Jun 18, 2020

Get free alerts when David L. Lacey files a new trade →